Edition:
India

ImmunoGen Inc (IMGN.OQ)

IMGN.OQ on NASDAQ Stock Exchange Global Select Market

8.95USD
17 Aug 2018
Change (% chg)

-- (--)
Prev Close
$8.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
639,539
52-wk High
$13.41
52-wk Low
$4.81

Select another date:

Fri, May 4 2018

BRIEF-ImmunoGen Reports Q1 Loss Per Share $0.30

* IMMUNOGEN REPORTS RECENT PROGRESS AND FIRST QUARTER 2018 OPERATING RESULTS

BRIEF-Immunogen Completes Interim Analysis For Forward I Phase 3 Trial Of Mirvetuximab Soravtansine

* IMMUNOGEN ANNOUNCES SUCCESSFUL COMPLETION OF INTERIM ANALYSIS FOR FORWARD I PHASE 3 TRIAL OF MIRVETUXIMAB SORAVTANSINE IN PLATINUM-RESISTANT OVARIAN CANCER

BRIEF-Immunogen Inc Files For Potential Mixed Shelf Offering‍​

* IMMUNOGEN INC FILES FOR POTENTIAL MIXED SHELF OFFERING; SIZE NOT DISCLOSED - SEC FILING‍​ Source text (http://bit.ly/2DablVK) Further company coverage:

Select another date: